BATF3 Antibody (841702) [DyLight 755]
Novus Biologicals, part of Bio-Techne | Catalog # FAB7437Z
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-ready, Intracellular Staining by Flow Cytometry
Label
DyLight 755 (Excitation = 754 nm, Emission = 776 nm)
Antibody Source
Recombinant Monoclonal Mouse IgG2B Clone # 841702
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
E. coli-derived recombinant human BATF3
Met1-Arg127
Accession # Q9NR55
Met1-Arg127
Accession # Q9NR55
Specificity
Detects human BATF3 in ELISA.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2B
Applications for BATF3 Antibody (841702) [DyLight 755]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Intracellular Staining by Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: BATF3
Long Name
Basic Leucine Zipper Transcription Factor, ATF-like 3
Alternate Names
JDP1, JUNDM1, SNFT
Gene Symbol
BATF3
Additional BATF3 Products
Product Documents for BATF3 Antibody (841702) [DyLight 755]
Product Specific Notices for BATF3 Antibody (841702) [DyLight 755]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...